Clinical trial
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve…
NCT00140413 · Children's Hospital Los Angeles, Other · Completed
Key facts
| NCT number | NCT00140413 |
|---|---|
| Title | Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia |
| Official title | Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia |
| Lead sponsor | Children's Hospital Los Angeles, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Growth Hormone Deficiency, Septo-Optic Dysplasia, Hypopituitarism |
| Intervention type | Drug |
| Interventions | Nutropin AQ |
| Enrollment | 20 |
| Start date | Dec 1, 2004 |
| Primary completion | Feb 1, 2014 |
| Completion | Feb 1, 2014 |
| First posted | Sep 1, 2005 |
| Last update posted | Apr 1, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: